Cytori Cell Research Institute, Inc. (3750.T)
JPY 904.0
(-0.88%)
JPY 904.0
(-0.88%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -772.74 Million JPY | 2.72% |
| 2022 | -794.35 Million JPY | -71.82% |
| 2021 | -462.32 Million JPY | 36.81% |
| 2020 | -731.67 Million JPY | -467.19% |
| 2019 | -129 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -239 Million JPY | 14.06% |
| 2023 Q2 | -216.94 Million JPY | -58.2% |
| 2023 Q1 | -137.13 Million JPY | 50.77% |
| 2023 Q4 | -278.11 Million JPY | -97.86% |
| 2023 Q3 | -140.56 Million JPY | 35.21% |
| 2023 FY | -772.74 Million JPY | 2.72% |
| 2022 Q3 | -134.84 Million JPY | 38.27% |
| 2022 FY | -794.35 Million JPY | -71.82% |
| 2022 Q4 | -278.53 Million JPY | -106.56% |
| 2022 Q2 | -218.44 Million JPY | 0.0% |
| 2021 FY | -462.32 Million JPY | 36.81% |
| 2020 FY | -731.67 Million JPY | -467.19% |
| 2019 FY | -129 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 229.476% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -55.523% |
| GNI Group Ltd. | 13.1 Billion JPY | 105.895% |
| Linical Co., Ltd. | 725.72 Million JPY | 206.479% |
| Trans Genic Inc. | 89.43 Million JPY | 964.017% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 45.809% |
| Soiken Holdings Inc. | -610 Million JPY | -26.678% |
| AnGes, Inc. | -11.96 Billion JPY | 93.543% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 31.054% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 91.888% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 840.891% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 10.605% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 30.819% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 38.768% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 3.233% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -129.052% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 35.881% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 42.143% |
| PeptiDream Inc. | 6.77 Billion JPY | 111.409% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 59.961% |
| Ribomic Inc. | -1.11 Billion JPY | 30.77% |
| SanBio Company Limited | -4.53 Billion JPY | 82.976% |
| Healios K.K. | -3.37 Billion JPY | 77.131% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 33.101% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 44.547% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 44.922% |
| StemRIM | -2.07 Billion JPY | 62.777% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 163.262% |
| FunPep Company Limited | -994 Million JPY | 22.259% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 13.054% |
| Stella Pharma Corporation | -760.3 Million JPY | -1.636% |
| TMS Co., Ltd. | -943.25 Million JPY | 18.077% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 0.342% |
| Cuorips Inc. | -588.48 Million JPY | -31.31% |
| K Pharma,Inc. | 366.05 Million JPY | 311.099% |
| Takara Bio Inc. | 3 Billion JPY | 125.732% |
| ReproCELL Incorporated | -409.29 Million JPY | -88.799% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 7084.923% |
| StemCell Institute Inc. | 413.75 Million JPY | 286.761% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 634.744% |
| CellSeed Inc. | -697.77 Million JPY | -10.744% |